Host-directed Drug Repurposing

Host-Directed Drug Repurposing is a drug repurposing strategy that targets host cellular factors and pathways to modulate infectious disease outcomes, distinguishing itself from pathogen-directed approaches by focusing on the host's biological mechanisms rather than microbial components.

14

Publications

597

Citations

117

Authors

48

Institutions

Publications per year

2017–2026

13

Authors

117

  1. ML
    Michal Letek

    Universidad de León, Spain

    2 publications · 58 citations

    2

    h-index

  2. NB
    Natalia Bravo-Santano

    University of Roehampton, United Kingdom

    2 publications · 58 citations

    2

    h-index

  3. YC
    Yolanda Calle

    King's College London, United Kingdom

    2 publications · 58 citations

    2

    h-index

  4. LM
    Luís M. Mateos

    Universidad de León, Spain

    2 publications · 58 citations

    2

    h-index

  5. VB
    Volker Behrends

    Imperial College London, United Kingdom

    2 publications · 58 citations

    2

    h-index

1–5 of 117

Venues

  1. mBio

    3 publications · 90 citations

    3

    h-index

  2. Scientific Reports

    2 publications · 58 citations

    2

    h-index

  3. Nature Chemical Biology

    1 publications · 48 citations

    1

    h-index

  4. Frontiers in Pharmacology

    1 publications · 55 citations

    1

    h-index

  5. British Journal of Pharmacology

    BJP · 1 publications · 110 citations

    1

    h-index

1–5